Arrowhead Pharmaceuticals Inc. (ARWR) Tops Q2 EPS by 11c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $82.37 +0.45%
Revenue Growth %: +89.5%
Financial Fact:
Change in value of derivatives: -113.36K
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: +89.5%
Financial Fact:
Change in value of derivatives: -113.36K
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q2 EPS of ($0.93), $0.11 better than the analyst estimate of ($1.04). Revenue for the quarter came in at $73.74 million versus the consensus estimate of $71.5 million.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley upgrades CDW on stronger AI-driven server demand
- Western Digital (WDC) June 26 weekly options active, share price down 8.8% into Micron (MU) quarter results
- BofA lists top 5 themes driving next $1tn in incremental semi sales
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
